Johnson & Johnson Quits Multibillion-Dollar Hep C Drug Program, Partners' Stocks Fall

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-janssen.jpg" NAME"Johnson & Johnson Quits Multibillion-Dollar Hep C Drug Program, Partners' Stocks Fall" ALT"Johnson & Johnson Quits Multibillion-Dollar Hep C Drug Program, Partners' Stocks Fall"September 11, 2017By Mark Terry...…

Continue ReadingJohnson & Johnson Quits Multibillion-Dollar Hep C Drug Program, Partners' Stocks Fall

FDA Calls Regeneron, Sanofi Carcinoma Drug a Breakthrough

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"FDA Calls Regeneron, Sanofi Carcinoma Drug a Breakthrough" ALT"FDA Calls Regeneron, Sanofi Carcinoma Drug a Breakthrough"September 8, 2017By Alex Keown, BioSpace.com Breaking News StaffTARRYTOWN... Source: BioSpace

Continue ReadingFDA Calls Regeneron, Sanofi Carcinoma Drug a Breakthrough